MYGN Q1 2026 Earnings EPS Misses Estimates as Strategic Investments Weigh on Results ICHR Q1 2026 Earnings EPS Beat Surprises Revenue Details Omitted WYY Q1 2026 Earnings EPS Surges Past Estimates with 108 Surprise Rocket Pharmaceuticals Inc RCKT Q1 2026 Earnings Clinical Progress Overshadowed by Slight EPS Miss and Capital Concerns REVB Q1 2026 Earnings Significant EPS Miss Amid EarlyStage Development TECX Q1 2026 Earnings EPS Miss as PreCommercial Biotech Advances Pipeline